Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.
D001943:Breast Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology; D003338:Corpus Luteum / Q000503:physiopathology*; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D006801:Humans; D007986:Luteinizing Hormone / Q000494:pharmacology; D008598:Menstruation; D006080:Ovarian Follicle / Q000503:physiopathology; D010060:Ovulation; D011374:Progesterone / Q000494:pharmacology; D011980:Receptors, Progesterone / Q000502:physiology; D012306:Risk
D004967:Estrogens; D011980:Receptors, Progesterone; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone